Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil Interaction Study with Ethanol and Cannabidiol in Healthy Volunteers
NCT04039919Phase 1Terminated
- Sponsor
- UCB
- Start
- Jul 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of padsevonil in focal onset seizure (6 arms), sponsored by UCB. Primary endpoints: Percentage of Smooth Pursuit Eye Movements, Maximum Observed Plasma Concentration at Steady State of Padsevonil and 3 more. Started Jul 2019; status: terminated.
02
Drugs
padsevonil
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT04039919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039919.